Cargando…
Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia
Bloodstream infections caused by Candida yeasts (candidemia) are associated with high morbidity and mortality. Diagnosis remains challenging, with the current gold standard—isolation from blood culture (BC)—being limited by low sensitivity and long turnaround time. This study evaluated the performan...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504845/ https://www.ncbi.nlm.nih.gov/pubmed/36135696 http://dx.doi.org/10.3390/jof8090972 |
_version_ | 1784796319736397824 |
---|---|
author | Koc, Özlem Kessler, Harald H. Hoenigl, Martin Wagener, Johannes Suerbaum, Sebastian Schubert, Sören Dichtl, Karl |
author_facet | Koc, Özlem Kessler, Harald H. Hoenigl, Martin Wagener, Johannes Suerbaum, Sebastian Schubert, Sören Dichtl, Karl |
author_sort | Koc, Özlem |
collection | PubMed |
description | Bloodstream infections caused by Candida yeasts (candidemia) are associated with high morbidity and mortality. Diagnosis remains challenging, with the current gold standard—isolation from blood culture (BC)—being limited by low sensitivity and long turnaround time. This study evaluated the performance of two nonculture methods: PCR and β-1,3-D-glucan (BDG) testing. The sera of 103 patients with BC-proven candidemia and of 46 controls were analyzed with the Fungiplex Candida Real-Time PCR and the Wako β-Glucan Test. The BDG assay demonstrated higher sensitivity than the multiplex PCR (58% vs. 33%). This was particularly evident in ICU patients (60% vs. 28%) and in C. albicans candidemia (57% vs. 37%). The earlier prior to BC sampling the sera were obtained, the more the PCR sensitivity decreased (46% to 18% in the periods of 0–2 and 3–5 days before BC, respectively), while BDG testing was independent of the sampling date. No positive PCR results were obtained in sera sampled more than five days before BC. Specificities were 89% for BDG and 93% for PCR testing. In conclusion, BDG testing demonstrated several advantages over PCR testing for the diagnosis of candidemia, including higher sensitivity and earlier diagnosis. However, BC remains essential, as BDG does not allow for species differentiation. |
format | Online Article Text |
id | pubmed-9504845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95048452022-09-24 Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia Koc, Özlem Kessler, Harald H. Hoenigl, Martin Wagener, Johannes Suerbaum, Sebastian Schubert, Sören Dichtl, Karl J Fungi (Basel) Article Bloodstream infections caused by Candida yeasts (candidemia) are associated with high morbidity and mortality. Diagnosis remains challenging, with the current gold standard—isolation from blood culture (BC)—being limited by low sensitivity and long turnaround time. This study evaluated the performance of two nonculture methods: PCR and β-1,3-D-glucan (BDG) testing. The sera of 103 patients with BC-proven candidemia and of 46 controls were analyzed with the Fungiplex Candida Real-Time PCR and the Wako β-Glucan Test. The BDG assay demonstrated higher sensitivity than the multiplex PCR (58% vs. 33%). This was particularly evident in ICU patients (60% vs. 28%) and in C. albicans candidemia (57% vs. 37%). The earlier prior to BC sampling the sera were obtained, the more the PCR sensitivity decreased (46% to 18% in the periods of 0–2 and 3–5 days before BC, respectively), while BDG testing was independent of the sampling date. No positive PCR results were obtained in sera sampled more than five days before BC. Specificities were 89% for BDG and 93% for PCR testing. In conclusion, BDG testing demonstrated several advantages over PCR testing for the diagnosis of candidemia, including higher sensitivity and earlier diagnosis. However, BC remains essential, as BDG does not allow for species differentiation. MDPI 2022-09-17 /pmc/articles/PMC9504845/ /pubmed/36135696 http://dx.doi.org/10.3390/jof8090972 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Koc, Özlem Kessler, Harald H. Hoenigl, Martin Wagener, Johannes Suerbaum, Sebastian Schubert, Sören Dichtl, Karl Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title | Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title_full | Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title_fullStr | Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title_full_unstemmed | Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title_short | Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia |
title_sort | performance of multiplex pcr and β-1,3-d-glucan testing for the diagnosis of candidemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504845/ https://www.ncbi.nlm.nih.gov/pubmed/36135696 http://dx.doi.org/10.3390/jof8090972 |
work_keys_str_mv | AT kocozlem performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT kesslerharaldh performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT hoeniglmartin performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT wagenerjohannes performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT suerbaumsebastian performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT schubertsoren performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia AT dichtlkarl performanceofmultiplexpcrandb13dglucantestingforthediagnosisofcandidemia |